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24 Abstract In the last 20 years, there has been an increasing interest in using
various seaweed extracts as prophylactic and/or therapeutic agents
in aquaculture. Up until now, most studies on the direct
antimicrobial effect of seaweeds have taken place in various parts
of Asia, particularly in India. All groups of seaweeds exhibit
significant antimicrobial properties against many infectious agents
of fish and shrimp, but the genera that appear to exhibit a broader
range of antibacterial properties are Asparagopsis spp. (red
seaweed) and Sargassum spp. (brown seaweed). The activity can
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be affected by many factors and the method of extraction is one of
the most important ones, as the extracts that are produced using
organic solvents appear more efficient. In fish, almost all published
information on bacterial pathogens comes from in vitro screenings,
where extracts of different seaweed species were tested against
many bacterial species. On the other hand, in shrimp, the studies
have been focusing on the antimicrobial effects of seaweed extracts
mainly against many Vibrio species. Regarding the viral pathogens,
in fish, there is only one published study on fish viruses (IHNV and
IPNV), while in shrimp there are many studies on WSSV. There are
only two published studies on fish parasites (Ichthyophonus hoferi
and Neobendenia spp.) and no studies on pathogenic fish and
shrimp fungi. Interestingly, there are no published studies on
salmons and carps, the main fish species that are extensively
farmed. When the antimicrobial properties were studied in vivo, the
seaweed extracts were either incorporated directly in the feeds (dry
or l ive) or added directly into the water in which the fish and shrimp
were reared. In the last case, the water-soluble antimicrobial
seaweed substances affected the communication between the
bacterial pathogens, rather than their growth. The development of
parasites was also affected. In addition, one study indicated that
short-term immersion of shrimp in seaweed extracts appeared to
have a therapeutic effect against Vibrio parahaemolyticus. On the
other hand, incorporation of the extracts into the feeds appeared to
be an effective delivery method for the prevention and treatment of
different infectious diseases. Up until now, there are no complete
studies on the pharmacodynamics and pharmacokinetics of
seaweed extracts in fish or shrimp. However, the findings indicate
that they can reduce the bacterial load within the tissues. Another
issue that has not been examined yet is the applicability of using
these extracts on a commercial scale. Currently, the increased
extraction cost inhibits the extensive use of these extracts. Other
methodologies, such the production of synthetic analogues with
similar properties, may decrease the production cost. Based on the
published studies, seaweed extracts exhibit promising antimicrobial
properties, but further research is needed before the complete
potential of seaweed extracts is assessed.
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11 Abstract In the last 20 years, there has been an increasing
12 interest in using various seaweed extracts as prophylactic and/
13 or therapeutic agents in aquaculture. Up until now, most
14 studies on the direct antimicrobial effect of seaweeds have
15 taken place in various parts of Asia, particularly in India. All
16 groups of seaweeds exhibit significant antimicrobial proper-
17 ties against many infectious agents of fish and shrimp, but the
18 genera that appear to exhibit a broader range of antibacterial
19 properties are Asparagopsis spp. (red seaweed) and
20 Sargassum spp. (brown seaweed). The activity can be affected
21 by many factors and the method of extraction is one of the
22 most important ones, as the extracts that are produced using
23 organic solvents appear more efficient. In fish, almost all
24 published information on bacterial pathogens comes from
25 in vitro screenings, where extracts of different seaweed spe-
26 cies were tested against many bacterial species. On the other
27 hand, in shrimp, the studies have been focusing on the anti-
28 microbial effects of seaweed extracts mainly against many
29 Vibrio species. Regarding the viral pathogens, in fish, there
30 is only one published study on fish viruses (IHNVand IPNV),
31 while in shrimp there are many studies on WSSV. There are
32 only two published studies on fish parasites (Ichthyophonus
33 hoferi and Neobendenia spp.) and no studies on pathogenic
34 fish and shrimp fungi. Interestingly, there are no published
35 studies on salmons and carps, the main fish species that are
36 extensively farmed. When the antimicrobial properties were
37 studied in vivo, the seaweed extracts were either incorporated
38directly in the feeds (dry or live) or added directly into the
39water in which the fish and shrimp were reared. In the last
40case, the water-soluble antimicrobial seaweed substances af-
41fected the communication between the bacterial pathogens,
42rather than their growth. The development of parasites was
43also affected. In addition, one study indicated that short-term
44immersion of shrimp in seaweed extracts appeared to have a
45therapeutic effect against Vibrio parahaemolyticus. On the
46other hand, incorporation of the extracts into the feeds ap-
47peared to be an effective delivery method for the prevention
48and treatment of different infectious diseases. Up until now,
49there are no complete studies on the pharmacodynamics and
50pharmacokinetics of seaweed extracts in fish or shrimp. How-
51ever, the findings indicate that they can reduce the bacterial
52load within the tissues. Another issue that has not been exam-
53ined yet is the applicability of using these extracts on a
54commercial scale. Currently, the increased extraction cost
55inhibits the extensive use of these extracts. Other methodolo-
56gies, such the production of synthetic analogues with similar
57properties, may decrease the production cost. Based on the
58published studies, seaweed extracts exhibit promising antimi-
59crobial properties, but further research is needed before the
60complete potential of seaweed extracts is assessed.
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63
64Introduction
65With an average annual growth rate of 8.9 % since 1970,
66aquaculture is considered to be the fastest growing food-
67producing sector in the world and accounts for about 36 %
68of the global fish supply and almost 60 % of the global shrimp
69supply (FAO 2014). In terms of quantity, farming of cyprinids
70dominates the aquaculture production, with 25.4 million T,
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71 while the production of salmonids and crustaceans (shrimp
72 and prawns) contributes with 3.2 and 4.3 million T, respec-
73 tively (FAO 2014). Diseases, either infectious or non-infec-
74 tious, are important limiting factors that affect the production
75 volume and consequently the production cost. In 2006, for
76 instance, for a global production of 1.6 million T of salmon,
77 the cost for sea lice treatments was estimated at 305 million €
78 (Costello 2009). It has been estimated that in Norway, the top
79 salmonid producer in the world, the cost of sea lice control is
80 about 0.19 €kg−1 of salmon (Costello 2009). Furthermore, it
81 was estimated that in 2010, over 77million USDwere spent in
82 Norway on fish diseases management, including the imple-
83 mentation of legislation and support to surveillance and con-
84 trol programmes (The Fish Site 2010).
85 The development of many vaccines, mainly against fish
86 pathogens, and the use of various antimicrobial agents have
87 reduced the impact of many diseases. However, there is cur-
88 rently an increasing demand for more environment-friendly
89 disease control schemes and many researchers have examined
90 alternative approaches. Among these approaches, the use of
91 various natural products that derive from different living or-
92 ganisms, such as plants (e.g. essential oils), animals (e.g.
93 chitozan) and seaweeds has received a lot of attention
94 (Romero et al. 2012).
95 Seaweeds, also known as macroalgae, are photosynthetic
96 multicellular aquatic organisms that can be found in almost
97 every aquatic environment, in all geographical areas. Humans
98 had realized their important value as early as 14,000 years ago
99 (Dillehay et al. 2008). The first reports of seaweeds growing
100 on ropes used for fish farming came from Japan, about
101 400 years ago (Buchholz et al. 2012). A more systematic
102 culture started in the 1950s, in order to meet the increasing
103 demand for seaweeds as food and mostly as sources of poly-
104 mers. In 2012, over 21 million tons of seaweeds were pro-
105 duced, over 96% of which were cultured in Asia (FAO 2014).
106 Many studies on different seaweed species have confirmed
107 their nutritional value. In particular, seaweeds are low in
108 calories, have high content of dietary fibres, are a good source
109 of polyunsaturated fatty acids DHA and EPA, and may con-
110 tain proteins up to 44 % dry matter with an amino acid profile
111 of interest (Holdt and Kraan 2011). The red and the green
112 seaweeds are generally rich in carbohydrates, whereas the
113 brown seaweeds are generally richer in soluble fibre and
114 iodine (Gupta and Abu-Ghannam 2011a). In some cases,
115 some essential amino acids might be limiting, as for example
116 tryptophan, while the concentration of other amino acids, like
117 taurine, can be high particularly in red algae (Dawczynski
118 et al. 2007). In addition to their nutritional value, seaweeds
119 exhibit interesting pharmacological properties, such as anti-
120 oxidant, anti-inflammatory, antimicrobial and even anticancer
121 properties (El Gamal 2010; Gupta and Abu-Ghannam 2011a;
122 Gupta and Abu-Ghannam 2011b; Holdt and Kraan 2011;
123 Mohamed et al. 2012). The active compounds include
124polysaccharides (e.g. fucoidan), various phytochemicals (e.g.
125phlorotannins), carotenoids, minerals, peptides and lipids
126(Gupta and Abu-Ghannam 2011b; Holdt and Kraan 2011). It
127is worth mentioning that some of these compounds, as for
128example phlorotannins, are not found in terrestrial plants.
129The present review focuses on published studies on the
130direct antimicrobial properties of seaweeds and their extracts
131against various pathogens of farmed fish and shrimp. Many of
132these extracts also exhibit significant immunostimulatory
133(Caipang et al. 2011) and antioxidant properties (Kang et al.
1342013; Wijesinghe et al. 2014), which can enhance the resis-
135tance and immune response against many infectious agents,
136but these will not be discussed in the present review.
137Control of infectious diseases in aquaculture
138In contrast to terrestrial farmed animals, most of the fish
139species that are farmed today have been recently domesticated
140from wild populations and thus they are still not well adapted
141to the conditions that exist in farms (Kibenge et al. 2012).
142Many of these conditions, such as crowding, regularly han-
143dling, improper water quality parameters and the use of arti-
144ficial commercial feeds, can cause various degrees of stress to
145fish, which in turn can make them more vulnerable to all
146infectious diseases (Huntingford et al. 2006). As a rule, the
147most common infectious diseases that are observed in farmed
148aquatic animals are those associated with bacterial pathogens
149(about 50 %), followed by the viral, the parasitic and finally
150the fungal diseases (McLoughlin 2006). Differences, depend-
151ing on the species and country, may exist. For instance, in
152farmed salmonids, bacterial diseases are not considered a
153major problem compared to the losses caused by viral agents,
154but in marine fish species bacterial diseases are far more
155important in terms of financial loss and frequency (Johansen
156et al. 2011).
157The control of the infectious diseases that affect the farmed
158aquatic animals relies on the use of effective prophylactic as
159well as therapeutic measures. Numerous studies have demon-
160strated that the extensive use of various chemotherapeutants
161used for the treatment of the parasitic, bacterial and fungal
162diseases in aquaculture have serious impacts on the environ-
163ment and increase the health risks for both humans and ani-
164mals (Burridge et al. 2010). It is well established for instance
165that the extensive use of various chemicals induces a strong
166selective pressure on the pathogens, resulting in the appear-
167ance of multi-resistant strains. Subsequently, through the hor-
168izontal exchange of genetic material that occurs between
169bacterial species, this resistance, which is an important viru-
170lence factor for many pathogens, is transferred to other path-
171ogens. Furthermore, the resistance to the antimicrobial agents
172that is developed in animal bacterial pathogens can be also
173transferred to human pathogens (Martinez 2009).
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174 In aquaculture, the main routes of administration of the
175 various chemotherapeutants are either via medicated feeds or
176 by immersion. Both of these methods can have a direct impact
177 on a wide range of bacterial species that live in the aquatic
178 environment. In both cases, it is very difficult to control the
179 leaching of the active substances to the immediate environ-
180 ment (Heuer et al. 2009) and thus residues of many antimi-
181 crobials are often found in the sediment under the fish and
182 shellfish farms (Petersen et al. 2002; Romero et al. 2012).
183 Miranda and Zemelman (2002) studied the presence of
184 oxytetracycline-resistant bacteria in the environment of Chil-
185 ean salmon farms and found that the number of
186 oxytetracycline-resistant bacteria was significantly increased
187 in the effluent water. The presence of these resistant bacteria
188 was associated with previous treatments that took place in the
189 farms. These findings are of great significance as many
190 in vitro studies have already demonstrated the transferability
191 of antibiotic resistance genes between fish or shrimp and
192 human pathogens (Heuer et al. 2009). Moreover, the use of
193 the various chemotherapeutants, including the antibiotics, has
194 negative effects onmany functions of the fish immune system.
195 Romero et al. (2012) in their review on the use of antibiotics in
196 aquaculture noted that treatment with oxytetracycline and
197 oxolinic acid could induce significant immunosuppression in
198 many fish species, while a less pronounced effect was ob-
199 served after a treatment with florfenicol. All these findings
200 stress therefore the urgency to minimize the use of any
201 chemotherapeutant in aquaculture and indeed many coun-
202 tries have already developed strict legislations concerning
203 their uses.
204 This necessity to reduce the use of chemicals is an impor-
205 tant issue not only in aquaculture but in the whole animal
206 farming industry. According to a report by World Human
207 Organization (WHO 2011), the implementation of effective
208 biosecurity measures, the development of new vaccines, the
209 use of prebiotics and probiotics, and good hygiene and man-
210 agement practices are quite important for the control of many
211 infectious diseases in both terrestrial and aquatic animal farm-
212 ing and can lead to a significant reduction in the use of
213 antibiotics in animal farming. Furthermore, new legislations
214 that would regulate and monitor the use of antibiotics should
215 be implemented, while the use of antibiotics as growth pro-
216 moters should be banned worldwide. Only qualified people,
217 preferably veterinarians, should be responsible for monitoring
218 the use of all chemicals used in animal farming. Experience
219 from the terrestrial animal husbandry indicates that indeed
220 strict legislations that require reduced use of antibiotics do
221 not necessary result in increased costs to the farmers, as for
222 example a survey in swine farms in Denmark has demonstrat-
223 ed (Aarestrup et al. 2010).
224 There is however a significant variation between countries
225 concerning the use of chemotherapeutants, which may reflect
226 the diverse degree of awareness of each society for
227environmental issues. This results in heterogeneity between
228the legislations in effect, in aquaculture producing countries.
229For example, Burridge et al., (2010) reported that the amount
230of antibiotics used in salmon farming between 2007 and 2008
231in Chile and Norway, the two main salmon producing coun-
232tries, was a few hundred metric tons in Chile and less than a
233metric ton in Norway. Furthermore, in many countries, fish
234and shellfish farmers use increased amounts of various anti-
235microbial substances, even on a daily basis, as a preventive
236measure (Heuer et al. 2009).
237As societies become more aware of the negative effects of
238the various treatments that are employed today in the control
239of the infectious diseases in aquaculture, various alternative
240approaches have been suggested. These include the use of
241probiotics to enhance the immune response of fish and shell-
242fish, the use of bacteriophages against bacterial pathogens and
243the use of various natural products, such as essential oils, as
244antimicrobial agents (Romero et al. 2012). Among them,
245seaweeds have also been examined as potential sources of
246antimicrobial substances (Gupta and Abu-Ghannam 2011b).
247Seaweeds versus fish and shrimp pathogens
248The dietary value of seaweeds, as potential substitutes for
249fishmeal, or as binding agents, has been extensively studied
250and the findings indicate that seaweed-based diets can be used
251for the farming of many aquatic organisms, such as fish,
252shrimp, sea urchins and abalones (Bindu and Sobha 2004;
253Henry 2012). Seaweeds have relatively simple cultivation
254methods and can grow fast. It is also possible to control the
255production of some of their bioactive extracts through the
256manipulation of the cultivation conditions (Plaza et al.
2572008). Recent studies have focused on culture systems inte-
258grating seaweed with fish or shrimp production. In these
259Integrated Multitrophic Aquaculture Systems (IMTA), the
260seaweeds play an important role first as biofilters and secondly
261as a source of biomass (Barrington et al. 2009). Seaweeds
262receive the nutrient-rich waste water from the fish or shellfish
263and use it for their growth. In this way, they can reduce the
264negative environmental impacts of fish farming through the
265removal of the waste materials (mainly N and P) that are
266released from the animals in the farms. The produced seaweed
267biomass adds market value to the production system, as they
268can later be used in food, or pharmaceutical industry (Al-
269Hafedh et al. 2012).
270The antimicrobial properties of seaweed extracts against
271many human and terrestrial animal pathogens are known since
272the end of the nineteenth century (Genovese et al. 2012).
273These antimicrobial properties can be affected by many fac-
274tors, such as the habitats, the cultivation method, the growth
275stage of seaweeds, the season and the method used for the
276extraction of the bioactive components (Karthikaidevi et al.
J Appl Phycol
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277 2009; Govindasamy et al. 2011). For example, Osman et al.
278 (2012), after screening many seaweed species against Bacillus
279 subtilis, Staphylococcus aureus, Streptococcus spp. and
280 Escherichia coli, found that green seaweeds and particularly
281 Ulva fasciata, tended to exhibit higher antimicrobial activity.
282 This was more pronounced when the green seaweeds were
283 collected in winter. On the other hand, Salvador et al. 2007
284 found that red seaweeds exhibited higher antimicrobial prop-
285 erties against many bacterial species, particularly the sea-
286 weeds which were collected in autumn. Regarding the method
287 of extraction, organic solvents generally tend to be more
288 efficient for the extraction of the active substances than water
289 (Abu-Ghannam and Rajauria 2013) and fractioned seaweed
290 extracts appear more effective compared to crude (Radhika
291 et al. 2014). One important characteristic of seaweeds that
292 may pose a health risk is that they are prone to absorb heavy
293 metals from their surrounding environment, especially if they
294 are located in particularly polluted areas (Bailey et al. 1999).
295 Furthermore, they may contain substances, such as kainoids,
296 aplysiatoxins and polycavernosides, which may be toxic to
297 humans and animals (Smit 2004). For example, significant
298 ichthyotoxic effects have also been reported by De Lara-Isassi
299 et al. (2000), who used Carassius auratus to assess the toxic-
300 ity of over 70 seaweed species. They concluded that
301 Rhodophyta tended to be more toxic, while Chlorophyta
302 appeared to be the least toxic. In some cases, the seaweed
303 extracts can be toxic to certain fish and shellfish species, even
304 at sub-antimicrobial concentrations (Mata et al. 2013).
305 In farmed fish, most studies on the antimicrobial properties
306 of seaweeds have focused on various bacterial pathogens (14
307 out of the 17 presented in this review), while fewer studies
308 exist on viral and parasitic pathogens (1 and 2, respectively,
309 out of the 17 presented in this review). On the other hand, in
310 farmed shrimp, the studies focused mainly on various patho-
311 genic vibrios and the White Spot Syndrome Virus. Interest-
312 ingly, although there are in vitro studies in the literature that
313 demonstrate the antifungal activities of many seaweed extracts
314 against human pathogenic fungi, such as Aspergillus spp.
315 and Candida albicans (Plaza et al. 2010; Omar et al.
316 2012), there are no similar studies on the main pathogenic
317 fish or shrimp fungi.
318 Despite the numerous studies on the antimicrobial effects
319 of seaweed extracts against fish and shrimp pathogens, there is
320 still limited information on the exact mechanism of action for
321 most of these extracts. The reason is that although an assess-
322 ment of any antimicrobial substance, as in the case of seaweed
323 extracts, should include an initial in vitro screening followed
324 by an in vitro study (Fig. 1), most studies on the antimicrobial
325 effects of seaweeds in fish and shrimp are either only in vitro
326 or only in vivo. For example, 8 out of the 39 studies on
327 seaweeds versus fish and shrimp pathogens discussed in this
328 review included both in vitro and in vivo assays (Tables 1 and
329 2). Furthermore, none of the eight studies on the White Spot
330Syndrome Virus included any preliminary in vitro study.
331Thus, it is not always clear if the observed protective result
332is either due to the direct antimicrobial effect, or due to
333immunostimulation, or the synergic effect.
334Bacterial pathogens
335The main identified active antibacterial compounds found in
336seaweeds are as follows: fatty acids, lipophilic and phenolic
337compounds, lectins, acetogenins, terpenes, alkaloids, poly-
338phenolics, isoprenoid metabolites and hydrogen peroxide
339(Mohamed et al. 2012). In general, these substances can (a)
340attack the bacterial cell walls and the cell membranes, which
341results in an extensive release of intracellular substances or/
342and disruption of the uptake and transportation of substances,
343as for example various phlorotannins ( Q4Hierholtzer et al. 2014);
344(b) reduce the protein and nucleic acid synthesis in the bacte-
345rial cells (Cai et al. 2014) and (c) inhibit respiration (Cai et al.
3462014). Phlorotannins, as many other terrestrial tannins do,
347may also form complexes with some extracellular bacterial
348enzymes (Stern et al. 1996), thus reducing their effects. In
349most cases, the effects are dose dependent.
350An area that has received a lot of attention is the effect of
351seaweeds and particularly some of their metabolites, on the
352quorum sensing mechanism, by which bacterial cells commu-
353nicate between each other. This process, which depends on the
354population density, involves the production of certain sub-
355stances, such as peptides, or lactones, which are then released
356into the extracellular environment. When the concentration of
357these substances increases beyond a certain level, they are
358then detected by specific receptors, located in the bacterial cell
359membranes, or cytoplasms. This in turn regulates the expres-
360sion of certain genes. Many Gram positive and negative
361bacteria use this process to collectively regulate many pro-
362cesses, such as bioluminescence, formation of biofilms and
363the production of various virulence factors (Manefield et al.
3642001; Q5Rutherford and Bassler 2014). Active substances re-
365leased from seaweeds, such as furanones, can disrupt this
366process, thus affecting the virulence of many pathogenic
367bacteria, as for example the virulence of many pathogenic
368Vibrio species (Defoirdt et al. 2006) (Fig. 2). Because of these
369properties and particularly the effect on the biofilm formation,
370seaweed extracts have also been studied as antifouling agents
371in aquaculture (Jha et al. 2013). It is worth mentioning that an
372important advantage of such quorum sensing inhibitors is that
373they do not induce strong selection pressure on the bacteria, as
374antibiotics do (Dobretsov et al. 2009).
375Numerous studies have focused on the study of the direct
376antibacterial (either bactericidal or bacteriostatic) properties of
377seaweed extracts against human bacterial pathogens, such as:
378B. subtilis, Enterococcus faecalis, Escherichia coli,
379Clostridium spp., Klebsiella pneumoniae, Pseudomonas
380aeruginosa, Proteus spp., Salmonella typhimurium, Shigella
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381 sonnei, Staphylococcus aureus, Staphylococcus epidermidis,
382 Streptococcus pyogenes and Vibrio cholerae (Vairappan and
383 Suzuki 2000; Vairappan et al. 2001; Xu et al. 2003; Christobel
384 et al . 2011; Vi jayabaskar and Shiyamala 2011;
385 Ganeshamurthy et al. 2012; Marudhupandi and Kumar
386 2013; Saritha et al. 2013). In most cases, only in vitro assays
387 were used to establish the antibacterial activities, such as dick
388 diffusion or tube dilution methods.
389 Most of the bacterial species that can cause diseases in fish
390 and shrimp are quite ubiquitous in the aquatic environment, as
391 for example many members of the genus Aeromonas and the
392 various pathogenic Vibrio species, such as Vibrio anguillarum
393 (also known as Listonella anguillarum), Vibrio alginolyticus
394 and Vibrio harveyi (Genovese et al. 2012; Cavalo et al. 2013).
395 Some of these bacteria, such as some pathogenic Vibrio spe-
396 cies, can affect both fish and shrimp and in many cases the
397manifestation and the progress of the associated diseases are
398affected by the presence of various stressful conditions. In
399comparison to human bacterial pathogens, fewer studies have
400been conducted to identify the antibacterial potential of sea-
401weed metabolites against these pathogens.
402Comparisons between the different studies on the antibac-
403terial properties of seaweeds against fish and shrimp are
404difficult, as different experimental protocols were used and
405particularly in relation to the extraction methods. However, it
406is worth noticing that in only 5 out of the 28 studies on fish
407and shrimp bacterial pathogens, water was used for the ex-
408traction (Table 1). Although none of the three groups of
409seaweeds appears to be significantly more effective, as differ-
410ent species belonging to all groups are effective against many
411bacterial pathogens, Asparagopsis spp. (red seaweed) and
412Sargassum spp. (brown seaweed) appear to exhibit a broader
Fig. 1 A general scheme used in
the assessment of antimicrobial
activity of seaweed extracts or
metabolites. The initial in vitro
screening indicates the best
candidates for the in vivo studies.
This stage can include many
assays, depending on the
bioactive component and its
potential application. The in vivo
studies are designed in such a way
so that the important information
is collected by using the
minimum number of animals.
Based on all available
information, the best method of
administration of the tested
extract is then proposed
J Appl Phycol
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413range of antibacterial properties (Table 3). Interestingly, most
414studies were conducted in Asia (mainly India), while consid-
415erably fewer in other parts of the world, which can be associ-
416ated with the extensive use of seaweed in the human diet in
417this area.
418Fish bacterial pathogens
419Antibacterial activities of seaweed extracts have been found
420against many Gram positive and Gram negative fish patho-
421genic bacteria, as many in vitro screenings have indicated
422(Table 3): many pathogenic Vibrio species, Aeromonas
423hydrophila and Aeromonas salmonicida, Edwarsiella tarda,
424Renibacterium salmoninarum, Photobacterium damselae
425sbsp piscicida, Pseudomonas anguilliseptica, Streptococcus
426iniae and Yersinia ruckeri (Vairappan and Suzuki 2000;
427Bansemir et al. 2004; 2006; Dubber and Harder 2008;
428Ganeshamurthy et al. 2012; Genovese et al. 2012; Rebecca
429et al. 2012; Singh et al. 2012; Cavallo et al. 2013;Maheswaran
430et al. 2013; Mata et al. 2013; Radhika et al. 2014).
431Few of these studies investigated the potential of using
432seaweeds to control bacterial pathogens in the aquatic envi-
433ronment (Fig. 2). Lu et al. (2008) demonstrated the antimicro-
434bial properties of Ulva clathrata in a series of experiments. In
435one experiment in particular, they added V. anguillarum in
436tanks containing cultures of the seaweed (10 g fresh
437algae L−1). The seaweed significantly reduced the growth of
438the bacterium in the water. However, the study did not include
439any experiment with fish and thus the applicability of these
440findings was not assessed. Mata et al. (2013) examined both
441in vitro and in vivo the antibacterial effect of the aqueous
442extracts bromoform and dibromoacetic acid from the red
443seaweed Asparagopsis taxiformis against the fish pathogen
444Streptococcus iniae. In that study, the extracts were added into
445the water containing barramundi (Lates calcarifer) fingerlings
446already infected with Streptococcus iniae. The findings indi-
447cated that addition of approximately 28 μg L−1 bromoform
448and 5 μg L−1 dibromoacetic acid could delay the growth of the
449bacterium in the water, but did not affect significantly the
450mortalities caused by Streptococcus iniae. This study however
451examined the activity of the extracts after the infection, while
452the possible prophylactic effect prior to infection was not
453investigated. Addition of higher concentration of the extracts
454was more effective against the pathogen, but also induced
455mortality in the fish.
456Shrimp bacterial pathogens
457Almost all studies related to the antibacterial effects of sea-
458weed extracts against shrimp pathogenic bacteria have fo-
459cused on the bacterial genus Vibrio spp., as this represents
460the main bacterial group that can induce significant mortalities
461in shrimp farming (Defoirdt et al. 2006; Baleta et al. 2011;
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462 Selvin et al. 2011; Dashtiannasab et al. 2012; Manilal et al.
463 2012; Cavalo et al. 2013; Silva et al. 2013; Sivakumar et al.
464 2014; Thanigaivel et al. 2014). When in vivo studies were
465 carried out, the extracts were delivered to the shrimp mainly
466 through enriched Artemia or medicated dry feeds. In one
467 study, the extracts were added into the water that contained
468 infected shrimp (Thanigaivel et al. 2014).
469 Traifalgar et al. (2009) examined and demonstrated the
470 overall protective effect of fucoidan extracted from Undaria
471 pinnatifida against V. harveyi in post-larvae black tiger shrimp
472 (Penaeus monodon). In that study, the shrimp that were fed
473 with 500–2,000 mg kg−1 body weight for 1 month exhibited
474 significantly lower mortality when infected artificially with
475 the bacterial pathogen. Interestingly, the shrimp that were fed
476 with the medicated feeds also exhibited improved growth
477 performance. Selvin et al. (2011) confirmed the protective
478 effect of U. fasciata extracts after feeding black tiger shrimp
479 post-larvae with medicated feed for 2 weeks. Subsequently,
480 they challenged the shrimp with four pathogens, namely Vib-
481 rio fischeri, V. harveyi, V. alginolyticus and Aeromonas spp.
482 The group of shrimp fed with 1 g kg−1 seaweed extract
483 exhibited significantly lower mortality. Similarly, Manilal
484 et al. (2012) examined the protective and therapeutic effect
485 of ethyl acetate partitioned fraction of Asparagopsis spp. in
486 black tiger shrimp post-larvae. For this, they fed the shrimp for
487 3 weeks and then challenged them with lethal doses of
488 V. harveyi, V. alginolyticus, Vibrio parahaemolyticus and
489 Photobacterium damselae. In this study, the authors examined
490 the therapeutic effect as the shrimp were also fed with the
491 medicated feed after the infection. Shrimp fed with 850 and 1,
492 150 mg kg−1 exhibited significantly increased survival rate. In
493 all the above studies, the exact mode of action of the extracts
494 was not determined.
495 In some studies, the authors attempted to explain the pro-
496 tect ive effect of the extracts only through their
497 immunostimulatory properties. For example, Sirirustananun
498 et al. (2011) studied the immunostimulatory effect of hot-
499 water extract of Gracilaria tenuistipitata by feeding white
500 shrimp (Litopenaeus vannamei) with 0.5, 1.0, and 2.0 g kg−1
501 dry diet for 14 days, before challenging them with
502 V. alginolyticus andWhite Spot Syndrome Virus. The extracts
503 induced a significant immunostimmulatory effect and
504 increased survival rates. However, the study did not include
505 any in vitro antibacterial assays, to indicate any possible direct
506 antibacterial effect, which could also play an important role.
507 Kanjana et al. (2011) studied both in vitro and in vivo the
508 protective role of some solvent extracts of the red seaweed
509 Gracilaria fisheri against V. harveyi. After an initial screening
510 using a disc diffusion assay, the authors used only the ethanol
511 extracts for further in vivo studies. For the in vivo study, the
512 authors fed the shrimp with enriched Artemia salina instars II
513 (either with 0.5 or 1.0 mg mL−1) for 2 weeks and then they
514 artificially infected shrimp post-larvae with the bacterial
515pathogens. The results indicated both an antibacterial as well
516as an immunostimulatory effect (i.e. increased total
517haemocyte and granulocyte counts, increased phenoloxidase
518(PO) and superoxide dismutase (SOD) activities and increased
519super oxide anion production). Immanuel et al. (2004) also
520studied in vitro and in vivo the protective role of some sea-
521weed s e x t r a c t s a g a i n s t t h e s h r imp p a t h og en
522V. parahaemolyticus by feeding Penaeus indicus post-larvae
523with Artemia franciscana preadults enriched with 400 mg L−1
524of butanolic extracts from Ulva lactuca and Sargassum
525wightii. In this study, the authors maintained the shrimp in
526water containing the pathogen for 30 days, while fed them
527with the seaweed extract-enriched Artemia. Interestingly, they
528found that the extract that exhibited the highest inhibition zone
529in the initial in vitro screening also induced reduced bacterial
530load in the internal organs of the infected shrimp and increased
531the survival rate.
532Thanigaivel et al. (2014) conducted a study which has
533demonstrated the potential of using seaweed extracts as alter-
534natives to antibiotics. The authors examined the antioxidant
535and antibacterial properties of an ethanol extract from the
536green seaweed Chaetomorpha antennina. Regarding the anti-
537bacterial properties, the authors first infected Penaeus
538monodon (mean weight 12 g) with V. parahaemolyticus and
539then treated the diseased shrimp by immersing them into water
540containing 250 mg L−1 of the seaweed extract for 12–48 h.
541This treatment resulted in 98 % of survival of the treated
542shrimp. In addition, i.m. injection of 25 μL of the extract per
543shrimp protected the animals when they were subsequently
544infected by the bacterial pathogen. This is the first report that
545shows the therapeutic effect of a short-term administration of
546seaweed extracts.
547A recent study by Sivakumar et al. (2014) demonstrated
548possible mechanisms that could explain the antimicrobial
549properties of U. fasciata against the pathogen V. harveyi.
550Thus, they demonstrated that solvent seaweed extracts re-
551duced the phospholipase, proteolysis, lipolysis and
552thermonuclease activities of treated bacteria. The study in-
553cluded also an immersion challenge trial, in which Penaeus
554monodon post-larvae were maintained in water containing
555V. harveyi for 30 days. Addition of 200 μg mL−1 of extracts
556into the water resulted in significantly reduced mortality.
557Defoirdt et al. (2006) examined the antibacterial effect of
558halogenated furanone extracted from the red seaweed Delisea
559pulchra against the shrimp bacterial pathogens Vibrio
560campbellii, V. harveyi and V. parahaemolyticus. They reported
561that this natural product at the concentration of 20 mg L−1
562could protect in vivo the brine shrimp Artemia franciscana
563against these bacterial pathogens, although the substance did
564not have any effect on the growth rate of the pathogens in the
565water. Higher concentrations were toxic to Artemia. The au-
566thors concluded that the protective effect was probably due to
567the disruption of the quorum sensing mechanism, as assessed
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568 by inhibition of bioluminescence, although a possible interac-
569 tion between furanone and the shrimps was not excluded.
570 Earlier, Manefield et al. (2000) had found that there is a link
571 between bioluminescence and toxin production in V. harveyi
572 and that the furanone that Defoirdt et al. (2006) also used
573 could decrease the production of toxin by the bacterium. They
574 also observed a protective effect in P. monodon, when they
575 injected intramuscularly the animals with furanone-treated
576 V. harveyi cultures. Rasch et al. (2004) examined the potential
577 of using a synthetic halogenated furanone at significantly
578 lower concentration (2.5 μg L−1) to minimize the mortality
579 caused by V. anguillarum in rainbow trout (Oncorhynchus
580 mykiss). Although no natural seaweed extracts were used,
581 the use of synthetic furanone decreased the mortality caused
582 by the bacterial pathogen, probably through the disruption of
583 the quorum sensing mechanism. As in the study by Defoirdt
584 et al. (2006), no effect of the synthetic furanone were observed
585 on the growth, the survival, the respiratory activity and the
586 motility of the bacterium.
587 Viral pathogens
588 Currently, no antiviral drugs are used in aquaculture and thus
589 the study of any substance with antiviral properties that can be
590 used against fish or shellfish viruses is of great importance.
591 The strategies that are currently used in aquaculture to control
592 viral diseases rely on the use of effective vaccines (mostly in
593fish farming) and the development of lines of animals resistant
594to certain diseases through selective breeding (Kibenge et al.
5952012). In shrimp farming, oral administration of
596immunostimulants has been suggested as a particularly prom-
597ising method against viral pathogens (Sivagnanavelmurugan
598et al. 2012), as vaccination is a rather experimental control
599method (Sudheer et al. 2012).
600The antiviral properties of seaweed extracts against human
601viruses are well reported. Various water-soluble extracts from
602red, brown and green seaweeds and particularly sulphated
603polysaccharides, exhibit antiviral properties against many vi-
604ruses, such as the herpes simplex viruses (Saha et al. 2012;
605Son et al. 2013), the Japanese encephalitis virus (flavivirus)
606(Chiu et al. 2012) and the influenza virus (Jiao et al. 2012).
607The antiviral activities against human viruses have been
608assessed mainly by in vitro studies, on cell lines, but also by
609in vivo studies, using experimental animals (e.g. mice). These
610studies have shown that the extracts can suppress the replica-
611tion of the viruses, and delay the manifestation of the disease
612symptoms, increasing the survival rates of the infected ani-
613mals. The active substances found in seaweed extracts include
614among others: sulphoglycolipids, carrageenans and fucoidans
615(Mohamed et al. 2012). The mode of action depends on the
616substance but also on the virus. For instance, many sulphated
617polysaccharides may bind to the surface of the viruses (mainly
618enveloped viruses), or to virus receptors on the host cell
619surface, thus interfering with the attachment and the
Fig. 2 Modes of administration of the seaweed extracts in fish and shrimp farming
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620 adsorption of the viruses to the host cells (Wang et al. 2012).
621 Some carrageenans can also exhibit post-binding inhibitory
622 effects, affecting the intracellular stages of the infection (Buck
623 et al. 2006), and particularly the virus transcription and repli-
624 cation (Wang et al. 2012). Factors that may affect the antiviral
625 properties of the sulphated polysaccharides include the sugar
626 composition, the main chain length, the sulphation level and
627 the sulphate pattern (Jiao et al. 2012). Phlorotannins from the
628 brown seaweed Ecklonia cava were also found to exhibit
629 inhibitory effect on HIV-1 reverse transcriptase and proteases
630 (Ahn et al. 2004).
631 Currently, there is only one study that indicates a possible
632 protective effect of seaweed extracts against fish viruses (In-
633 fectious Hematopoietic Necrosis Virus and Infectious Pancre-
634 atic Necrosis Virus), while there are many studies on White
635 Spot Syndrome Virus of shrimp. In contrast to bacterial path-
636 ogens, both water and organic solvents were used for the
637 extraction (Table 2). The seaweed species that exhibited the
638 antiviral activity were as follows: for WSSV: red seaweeds—
639 G. tenuistipitata, brown seaweeds—Sargassum spp. and
640 Cladosiphon okamuranus, green seaweeds—Acrosiphonia
641 orientalis; and for IHNV and IPNV—the red seaweed
642 Polysiphonia morrowii (Table 3). All studies discussed in
643 the present review took place in Asia, probably because there
644 is an increased interest to develop effective control strategies
645 against WSSV, as no effective vaccines are yet available for
646 the shrimp industry.
647 Fish viral pathogens
648 Kim et al. (2011) used cell-based assay to assess the antiviral
649 properties of the red alga Polysiphonia morrowii. They found
650 that the 80 % (v/v) methanolic extract had significant antiviral
651 activity against two important fish viruses, the Infectious
652 Hematopo ie t i c Nec ros i s Vi rus ( IHNV— f ami ly
653 Rhabdoviridae) and the Infectious Pancreatic Necrosis Virus
654 (IPNV—family Birnaviridae). Although, the study was
655 in vitro and the authors did not provide any evidence on the
656 mechanism of action of these extracts on the viruses, the
657 results indicate the potential of using seaweed extracts against
658 these viruses.
659 Shrimp viral pathogens
660 The White Spot Syndrome Virus (WSSV—family
661 Nimaviridae) is the major pathogen affecting the shrimp pro-
662 duction worldwide. WSSV can induce up to 100 % mortality
663 within a few days, particularly at larval and juvenile stages.
664 Various authors studied therefore the antiviral properties of the
665 seaweed extracts in particular against the WSSV by adminis-
666 trating the extracts to shrimp either via enriched Artemia
667 nauplii (Immanuel et al. 2010; Immanuel et al. 2012;
668 Sivagnanavelmurugan et al. 2012) or through medicated feeds
669(Chotigeat et al. 2004; Manilal et al. 2009). Based on these
670studies, the effective concentration of extracts that can be used
671to enrich Artemia ranges from 400 to 750 mg L−1, while the
672shrimp should be fed for about 20 days prior I order to acquire
673protection against the virus. On the other hand, medicated
674feeds were efficient when the seaweed extracts were added
675at a concentration of 250–500 mg kg−1 body weight. The
676active components were found to be polysaccharides, in par-
677ticular fucoidans and sodium alginates (Takahashi et al. 1998;
678Chotigeat et al. 2004; Manilal et al. 2009; Immanuel et al.
6792012; Sivagnanavelmurugan et al. 2012). Chotigeat et al.
680(2004) examined in particular the prophylactic and therapeutic
681effect of crude fucoidan extracted from Sargassum polycystum
682against WSSV. Black tiger shrimps of different sizes were fed
683with medicated feed 4 days prior to and 10 days after an
684experimental infection. The results showed that crude
685fucoidan at the concentration of 400 mg kg−1 of body weight
686day−1 increased significantly the survival rate, while at the
687same time increased the phagocytic activity of the shrimp
688haemocytes. Similar results were obtained in an earlier study
689by Takahashi et al. (1998) who fed kuruma shrimp (Penaeus
690japonicus) with fucoidan extracted from the brown seaweed
691C. okamuranus, at the concentration of 100 mg kg−1 of body
692weight day−1.
693In another study by Balasubramanian et al. (2006), the
694extracts, after their extraction by either water or organic sol-
695vents, were first mixed with suspensions of WSSV in order to
696de-activate the virus. Subsequently, the treated viral prepara-
697tions were injected intramuscularly into marine shrimp
698(Penaeus indicus) and freshwater crab (Paratelphusa
699hydrodomous). Aqueous extracts of Sargassum weightii at a
700concentration of 3 mg per animal resulted in significantly less
701mortality in the infected animals.
702In all the above studies on WSSV, the mechanisms
703explaining the antiviral action of these seaweed extracts were
704not determined. However, apart from the immunostimulatory
705effects, a direct antiviral effect of the extracts similar to that
706observed in other viruses cannot be excluded as a study by
707Rudtanatip et al. (2014) indicates. These authors reported that
708sulphated galactans isolated from the red seaweed G. fisheri
709attached to certain sites on the viral envelope and hence
710inhibited the attachment of the viruses to the host cells.
711Parasitic pathogens
712The antiparasitic properties of many seaweed extracts have
713been studied on a wide range of human parasites, such as
714protozoa (e.g. Plasmodium spp. and Trichomonas spp.) (Moo-
715Puc et al. 2008; Vonthron-Sénécheau et al. 2011), helminthes
716(e.g. Ascaris spp.) (Higa and Kuniyoshi 2000) and insects
717(e.g. mosquito larvae) (Bianco et al. 2013). The mechanism
718of action varies according to the extracts and the parasites.
719Thus, the extracts can either interfere with the binding of the
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720parasites to the target host cells and the subsequent invasion
721(Patel 2012) or have a direct toxic effect on the parasites. For
722example, Moo-Puc et al. (2008) demonstrated the direct
723antiprotozoan activity of organic extracts derived from many
724seaweed species against Trichomonas vaginalis trophozoites,
725while Bianco et al. (2013) reported significant larvicidal ac-
726tivity of the red seaweed Laurencia dendroidea organic ex-
727tracts against the larval stages of the mosquito Aedes aegypti.
728Despite the many studies on human parasites, the information
729on the antiparasitic properties of seaweeds against fish para-
730sites is limited, while there are no published studies on shrimp
731parasites.
732Hutson et al. (2012) examined the effect of aqueous ex-
733tracts from two seaweeds Ulva spp. and Asparagopsis
734taxiformis on the parasitism of barramundi (L. calcarifer) by
735the monogenean ectoparasiteNeobenedenia spp. The extracts,
736at the concentration of 1/100 v/v, mainly affected the initial
737stages of the cycle of the parasites. In particular, they inhibited
738the embryonic development, delayed the time of first and last
739hatching, and reduced the hatching success rate of the parasite.
740The Asparagopsis taxiformis extracts appeared substantially
741more effective. Both extracts however had no significant
742effect on the survival of the attached adult parasites or the
t3:1 Table 3 Seaweed species tested against fish and shrimp pathogens. The
table summarizes the findings presented in Tables 1 and 2 of this review
t3:2 Seaweed genus/species Geographical
area
Pathogen
t3:3 Red seaweeds
t3:4 Asparagopsis
armata
Atlantic,
France
Vang, Pang, Asal, Ahyd, Yruc
t3:5 Asparagopsis
taxiformis
Italy Valg, Vpar, Vhar, Vvul, Asal,
Pdad, Pdap,
t3:6 Asparagopsis
taxiformis
Australia Sini, Neo
t3:7 Ceramium rubrum North Sea Asal, Valg, Yruc
t3:8 Delisea pulchra India Vhar, Vcam, Vpar
t3:9 Delisea pulchra Australia Vhar
t3:10 Gracilaria corticata India Vpar, Ahyd, Valg, Vhar, Vfis
t3:11 Gracilaria dura Italy Vord, Valg
t3:12 Gracilaria fisheri Thailand Vhar
t3:13 Gracilaria gracilis Italy Vsal
t3:14 Gracilaria
tenuistipitata
Taiwan Valg, WSSV
t3:15 Gracilariopsis
longissima
Southern
Italy
Valg, Vvul
t3:16 Hypnea musciformis India Vhar, Vfis
t3:17 Laurencia
chondrioides
Gran Canaria Vang, Pang, Asal,
Ahyd, Yruc, Pdapi
t3:18 Mastocarpus
stellatus
North Sea Asal, Vang
t3:19 Polysiphonia
morrowii
South Korea IHNV, IPNV
t3:20 Green seaweeds
t3:21 Acrosiphonia
orientalis
India WSSV
t3:22 Caulerpa racemosa India Vpar, Ahyd
t3:23 Caulerpa
sertulrioides
India Vpar, Ahyd
t3:24 Chaetomorpha
antennina
India Vpar, Ahyd
t3:25 Chaetomorpha linum Southern
Italy
Vvul, Vord
t3:26 Chladophora
rupestris
Southern
Italy
Vvul, Vsal, Vord
t3:27 Codium tomentosum India Valg, Vhar, Vfis
t3:28 Halimeda
micronesia
India Valg, Vpar, Ahyd, Etar
t3:29 Ulva clathrata China Vang
t3:30 Ulva fasciata India Valg, Vhar, Vfis, Aero
t3:31 Ulva prolifera Southern
Italy
Vord
t3:32 Ulva lactuca India Vpara
t3:33 Ulva reticulata Malaysia Valg, Vpar, Ahyd
t3:34 Ulva spp. Australia Neo
t3:35 Brown seaweeds
t3:36 Cladosiphon
okamuranus
Japana WSSV
t3:37 Dictyota dichotoma India Valg
t3:38 Fucus vesiculosus Egypta Icth
t3:39 Laminaria digitata North Sea Vang, Pdada, Yruc
t3:40 Padina gymnospora India Vpar, Ahyd, Valg,
t3:41 Padina gymnospora Brazil Vpar, Vbra, Vxui, Vnav
t3:42Table 3 (continued)
Seaweed genus/species Geographical
area
Pathogen
t3:43Padina
tetrastomatica
India Valg, Vhar, Etar, Ahyd
t3:44Sargassum
duplicatum
India WSSV
t3:45Sargassum latifolium Persian Gulf Vpar, Valg, Vhar
t3:46Sargassum
oligocystum
Philippines Vpar, Valg, Vhar
t3:47Sargassum
polycystum
Thailand Vhar, WSSV
t3:48Sargassum wightii India Vpar, Ahyd, Valg, Vhar, Vfis,
Rsal, WSSV
t3:49Stoechospermum
marginatum
India Ahyd
t3:50Undaria pinnatifida Japan Vhar
t3:51Turbinaria ornata India Rsal
The relevant references are cited in Tables 1 and 2
Aero Aeromonas spp., Ahyd Aeromonas hydrophila, Asal Aeromonas
salmonicida, Etar Edwardsiella tarda, Icth I. hoferi, IHNV Infectious
Hematopoietic Necrosis Virus, IPNV Infectious Pancreatic Necrosis
Virus,NeoNeobenedenia spp., Pang Pseudomonas anguilliseptica, Pdad
Photobacterium damselae sbsp damselae, Pdap Photobacterium
damselae sbsp piscicida, Rsal R. salmoninarum, Sini Streptococcus iniae,
Valg V. alginolyticus, Vang V. anguillarum, Vbra Vibrio brasiliensis,
Vcam Vibrio campelii, Vfis V. fischeri, Vhar V. harveyi, Vord Vibrio
ordalii, Vpar V. parahaemolyticus, Vsal Vibrio salmonicida, Vvul Vibrio
vulnificus, Vxui Vibrio xuii, WSSV White Spot Syndrome Virus, Yruc Y.
ruckeri
a Area where the study took place
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743 infection success of oncomiracidia. The authors suggested that
744 these extracts could be particularly effective in either closed or
745 integrated farming systems, if these seaweed species are co-
746 cultivated along with the fish. There was however no assess-
747 ment of the applicability of this method under farming
748 conditions.
749 Ghany and Alla (2008) reported that when Nile tilapias
750 (Oreochromis niloticus) experimentally infected with the pro-
751 tozoan fish endoparasite Ichthyophonus hoferi, they exhibited
752 reduced mortality when fed post-infection with extracts from
753 the seaweed Fucus vesiculosus (2 g kg−1 body weight) for
754 3 months. It should be noted though that the study did not
755 provide adequate information on the characteristics of the
756 extracts, or how they were produced.
757
758 Conclusions and future priorities
759 Aquaculture is a growing industry and infectious diseases
760 constitute one of the main limiting factors, affecting the pro-
761 duction volume and cost. Assessment of the exact effects of
762 the microbial diseases on the aquaculture production is very
763 difficult, as there are direct and indirect effects. Stressful
764 conditions can also compromise the immune system of fish
765 and shellfish and subsequently reduce their response to any
766 infectious agent (Huntingford et al. 2006).
767 Seaweeds represent a group of aquatic organisms which is
768 an important part of the marine food chain, as well as the
769 human diet. In addition to their nutritional value, they also
770 exhibit antimicrobial, immunostimulatory and antioxidant
771 properties. In the last 20 years, there is an increasing interest
772 in using various seaweed extracts as prophylactic and thera-
773 peutic agents in aquaculture.
774 Although there are fewer published studies on fish and
775 shrimp pathogens compared to human and husbandry animal
776 pathogens, the findings indicate that seaweeds can play an
777 important role in the upcoming aquaculture sustainable
778 practices.
779 There are few published studies, which included both
780 in vivo and in vitro assessment of the direct antimicrobial
781 properties of seaweeds. Regarding the fish pathogens, almost
782 all published information comes from in vitro screenings,
783 where extracts of different seaweed species were tested
784 against many bacterial pathogens, while there is only one
785 published study on fish viruses (IHNV and IPNV) and two
786 on fish parasites (I. hoferi and Neobendenia spp.). Interesting-
787 ly, there are no published studies on salmons and carps, which
788 are extensively farmed. The studies on shrimp have focused
789 on the antimicrobial effects of seaweed extracts mainly against
790 many Vibrio species and WSSV. Although all the studies
791 indicate the overall positive effect of the extracts, they do
792 not elucidate the exact mechanism of action and particularly
793within the animal tissues (Fig. 1). Furthermore, although it is
794known that many seaweed extracts also exhibit
795immunostimulatory properties, which can contribute to the
796protective effect, in most studies these effects were never
797examined in parallel to the antimicrobial effects.
798In general terms, all three groups of seaweeds (red, green
799and brown) exhibit antimicrobial properties, but the genera
800that appear to exhibit a broader range of activity are
801Asparagopsis spp. (red) and Sargassum spp. (brown). It
802should be noted though that comparison between species is
803difficult, as there are many factors that can affect the antimi-
804crobial properties, and the same seaweed species may exhibit
805different properties depending on the season or the geograph-
806ical area.
807The extraction method is also an important factor that can
808affect the efficacy of the produced extracts. In 27 out of 39 of
809the studies that are presented in this review, organic solvents
810were used for the extraction rather than water.
811The modes of delivery of the active seaweed substances
812can either be through the water (released directly from the
813seaweeds or added into it after their extraction), or through
814medicated feed (again after their extraction), as outlined in
815Fig. 2. In the first case, mainly water-soluble substances of
816seaweeds can be released or added into the aquatic environ-
817ment of the farmed fish and shrimp. These substances appear
818to affect the quorum sensing mechanism in bacteria with
819limited effects on the bacterial growth. When the extracts are
820added into the feeds (live or dry), they can act directly against
821the pathogens or by stimulating the immune system. In addi-
822tion, there are no complete pharmacodynamic and pharmaco-
823kinetic studies, which can demonstrate the exact mode of
824action of any seaweed extract. This important issue should
825be included in future studies.
826An important point that none of the published studies
827presented in our review has examined is the applicability of
828using any of these extracts on a commercial scale. The main
829issues related to this are the extraction cost and how the
830extracts can be delivered to fish or shrimp under the intensive
831farming conditions.
832The production cost of seaweeds varies according to the
833country and it can be between € 160 and € 330 T−1 dry, in Asia
834and Europe, respectively, but new seaweed culture techniques
835are expected to reduce this cost (Bruton et al. 2009). For the
836extraction of the active substances, there are a few methods
837that are available on a commercial scale and at the moment the
838cost of these methods is relatively high (Takahashi et al. 1998;
839Ibañez et al. 2012). The yield of the active substances extract-
840ed from seaweed is between less than 1 % up to 40 % of the
841dry algal mass, depending on various factors, such the metab-
842olite, seaweed species and season (Pereira and Costa-Lotufo
8432012). Possible solutions to the high production cost can be
844the production of synthetic seaweed active compounds, as
845some of them exhibit properties similar to the natural
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846 substance (Rasch et al. 2004; Defoirdt el. 2006), or the incor-
847 poration of the responsible seaweed genes into microorganism
848 asQ6 Pereira et al. (2012) suggested. However, some of these
849 techniques have many complex steps and can be applied only
850 when the antimicrobial effect of the natural analogs is well
851 demonstrated.
852 As discussed before, one mode of action is through the
853 inhibition of the quorum sensing mechanism of the bacterial
854 pathogens that exist in the water column, prior to infection.
855 The active substances need to be constantly added into the
856 water for long periods, as Rasch et al. (2004) did during their
857 experimental challenges. Mata et al. (2013) examining the
858 therapeutic effect of seaweed extracts also added the extracts
859 to the water containing infected fish for a long period. In
860 practice, this method can only be applied on land facilities,
861 when fish are reared in small tanks and the water exchange
862 rate is low (e.g. in hatcheries). In addition, the administration
863 of therapeutics extracted from seaweed must be monitored
864 continuously, as sudden increases of the concentration of the
865 antimicrobial substance can be lethal (Rasch et al. 2004; Mata
866 et al. 2013) and exposure periods must be as short as possible
867 (Thanigaivel et al. 2014). More studies on short-term expo-
868 sures are therefore required to confirm the efficacy of such
869 treatments, particularly against parasitic pathogens.
870 The safest delivery method reported is through medicated
871 feed, as the dose of the extract per animal treated can be
872 calculated more accurately. This method applies to all farming
873 systems and can decrease the bacterial load in the tissues
874 (Immanuel et al. 2004). Thus, this method of delivery will
875 probably be the most effective and applicable one. Neverthe-
876 less, more studies investigating the effect seaweed extracts on
877 pathogens are necessary to support this hypothesis.
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